The Department of Health and Human Services signed waivers authorizing every member of the preventive care panel to retain their seats regardless of competing financial interests. Disclosed documents show that multiple doctors on the panel own private medical practices positioned to profit directly from specific care recommendations. Other conflicts cleared by federal officials include stock ownership in pharmaceutical manufacturers and medical device companies. Furthermore, the level of conflicting holdings is not uniform across the board, as newer appointees carry more extensive entanglements.
Key points
Blanket federal waivers shield preventive care panel members from standard financial conf…: Blanket federal waivers shield preventive care panel members from standard financial conflict-of-interest disqualifications.
The grant of waivers contradicts Robert F. Kennedy Jr.'s public rhetoric targeting corpor…: The grant of waivers contradicts Robert F. Kennedy Jr.'s public rhetoric targeting corporate influence within the healthcare sector.
Financial conflicts on the advisory board range from university employment to deeper comm…: Financial conflicts on the advisory board range from university employment to deeper commercial investments held by newer members.
Sources checked by our analysis pipeline: 1
WASHINGTON — Federal officials have granted blanket waivers to every member of an influential, yet little-known federal panel that evaluates preventive medical services, allowing them to serve despite some having clear financial stakes in decisions they might make.
The waivers, signed by a top federal official and obtained by STAT, show a willingness by health secretary Robert F. Kennedy Jr.’s department to overlook financial conflicts of interests, though Kennedy frequently decries corporate influence in health care. In the case of two members, the documents show that they own private medical practices that could profit should the panel recommend particular types of care.
Other conflicts being waived include stock holdings in pharmaceutical and medical device companies and employment at public research universities that provide medical care. Some members of the U.S. Preventive Services Task Force, especially the newer ones, have more extensive conflicts than others.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Researchers have identified a molecular signal in the blood that can detect microscopic changes occurring before the development of ovarian cancer. Published in Nature Medicine, the study led by Rajan Gogna of the Hoag Family Cancer Institute represents a shift from past efforts, focusing on identifying early warning signs rather than locating already formed tumors. Because ovarian cancer frequently begins as precancerous lesions in the fallopian tubes known as serous tubal intraepithelial carcinoma (STIC), findin…
International health monitors are reviewing domestic epidemiological data following years of escalating outbreaks and at least eight fatalities this year. A revocation would mark a major setback for the nation's public health infrastructure, which previously eradicated sustained domestic transmission. Meanwhile, the decision arrives as federal health agencies concurrently face scrutiny over newly granted ethics waivers to advisory panel members with financial conflicts.
Health authorities have initiated the official 42-day countdown required to declare the nation free of the deadly pathogen after successfully containing its first-ever outbreak. Rapid contact tracing and strict isolation protocols successfully prevented broader community transmission following the initial imported case from the Democratic Republic of Congo. Kenyan officials are now pressing international partners to lift disruptive travel bans and visa restrictions instituted during the emergency.